Biohaven, Yet Another Rival To Argenx In Autoimmune Drugs, Just Rocketed 33%
Immunovant Parlays Its Shot At Rivaling Argenx Into A $300 Million Offering
Immunovant Doubles — And Slugs Argenx — As Autoimmune Disease Battle Heats Up
Dow Jones Futures Rise Ahead Of Fed Decision; Tesla Leads 12 Stocks To Watch
New S&P 500 Entrant Airbnb And DKNG Lead 5 Stocks Near Buy Points
This New S&P 500 Entrant Leads 5 Stocks Near Buy Points
How IBD Stock Of The Day Argenx, A Top-Notch Biotech, Is Dominating — With One Drug
Top AI Stock ANET Leads 5 Stocks Near Buy Points In Tough Market
Top AI Stock ANET Leads 5 Stocks Near Buy Points In Tough Market
Argenx Beats Earnings Expectations As Sales Of 'Megabuster' Drug Grow 260%
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Amicus Therapeutics Stock Scores Healthy Relative Strength Upgrade
ADRs End Higher, Foresight Autonomous and Argenx Trade Actively
Argenx Launches $750M Global Offering
The Multibillion-Dollar Opportunity That Sent Argenx Flying 28% Into A Breakout
Argenx Shares Hit 52-Week High After Positive Vyvgart Hytrulo Trial Results
Argenx, Zai Lab Shares Rise After Positive Trial Results for Vyvgart Hytrulo
Argenx Says FDA Approves Vyvgart Hytrulo Injection to Treat Neuromuscular Disease gMG
US Futures Rise, European Stocks Mixed as Shares Track US Debt Ceiling Talks
This Top Pro Invests in Healthcare Trailblazers. 4 of Her Favorite Plays.
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.